Item Added to Cart



A Better World for Pets

At Wisdom Health, our mission is to facilitate responsible pet care by enhancing the well-being and relationship between pets, pet owners, breeders, shelters and veterinarians through valuable insights into pets as individuals

We have spent nearly two decades researching canine genetics starting with our instrumental role in the Canine Genomics project in 1999. Wisdom Health was established in 2005 and since that time our team of scientists and geneticists has been analyzing canine DNA and identifying the most useful DNA SNP markers to distinguish between different dog breeds, detect disease mutations, analyze traits and inform on diversity within breeds. We use more than 4000 strategically placed markers to report on this information to consumers, breeders and veterinarians worldwide.

Through our extensive work with breeders and breed clubs we have been able to obtain the samples necessary to create genetic signatures for more than 250 breeds, types and varieties. These samples have also enabled us to continue our valuable work on disease and trait detection far beyond this group of breeds. To date, the Wisdom Health database of breed signatures is the largest in the world with more than 12,000 samples.


We continue to work with researchers in the field such as Washington State University to license the MDR1 multi-drug sensitivity test, and Genoscoper Laboratories® in Finland for our extensive disease screening and diversity testing to expand our offerings for consumers, breeders, veterinarians, and shelters alike. We believe in the important role genetics can play in making a better world for our four-legged family members. By using DNA to discover a dog's ancestry and screen for genetic diseases, pet owners and veterinarians can work together to proactively address the one-of-a-kind needs of each unique dog. Simply put, when you know the breeds in your dog you know a lot more about how to make them happy and healthy.


Wisdom Health acquires Optigen, LLC.


Wisdom Health acquires Genoscoper Laboratories in Helsinki Finland.

Mars Veterinary change their business name to Wisdom Health™


OPTIMAL SELECTION Test for Feline breeders is launched making it the first panel disease and trait test for felines on the market.

WISDOM PANEL 4.0 testing with the addition of trait analysis and EIC screening is launched.


OPTIMAL SELECTION Canine Breeder test was re-launched with new disease and trait analysis features.

A Division of Mars Petcare completes the transition of Mars Veterinary into the Mars Petcare segment.

WISDOM PANEL 2.5 and 3.0 are launched into the consumer channel featuring MDR1 testing.


WISDOM PANEL 2.0 is launched into the consumer channel.

Banfield CTS headquarters becomes the permanent home of the Mars Veterinary Business unit.


OPTIMAL SELECTION™ Canine Breader test was launched for diversity analysis only.


WISDOM PANEL Insights is launched into the consumer channel.


WISDOM PANEL™ MX is launched into the U.S. veterinary channel.


A Division of Mars Symbioscience is formed and Mars Veterinary becomes part of the Symbioscience incubator segment based at Nottingham Laboratory.


The Breed Determination Patent is licensed from the Fred Hutchinson Cancer Research Center.


Genomics Technology Platform (Profile Technology) is created for researching canine DNA solutions at Waltham and Nottingham University Laboratories.